Selection between sunitinib and ripretinib using mutation analysis for gastrointestinal stromal tumor patients progressing on imatinib.

ABSTRACT:

SUBMITTER: Joensuu H 

PROVIDER: S-EPMC11535786 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature